The extended agreement comes after positive results following months of tests on InnoCan's CBD-loaded liposomal platform technology -- which...
Buds n Duds
Buds n Duds
Buds n Duds
Buds n Duds
Buds n Duds
Nano caps
TruTrace’s blockchain-secured cannabis tracking technology sees strong adoption
Over 10 major producers have flocked to the StrainSecure platform to track strains of medical...
As edibles and infused beverages hit Canadian shelves, BevCanna's Emma Andrews shares her...
The Toronto-based company is focused on identifying, acquiring and developing assets in the...
TGOD’s operations are focused on medical cannabis markets in Canada, Europe, the Caribbean and...
Armed with a new partnership with Canada's largest pharmacy and an international cultivator,...
Lexaria BioScience (OTC: LXRP-CSE: LXX) CEO Chris Bunka and Case Mandel, CEO of Cannadips joined Steve Darling from Proactive Vancouver on Skype with news the company has signed a licensing deal for their DehydraTech technology with Cannadips from Humboldt, California. Bunka telling Proactive...
Market Report
Market Report
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
